Regarding timing, regenerative treatments can be initiated in the early stages, even during ongoing weight loss
What is not known yet All three records show no posted results, so the actual numbers whether metoprolol exposure shifted, how retatrutide exposure differed in end-stage renal disease, and what happened to measured GFR are not public
As breakthrough medications like Wegovy (semaglutide) or Ozempic (semaglutide) and Mounjaro (tirzepatide) or Zepbound (tirzepatide) transform obesity management, new questions arise: Can these medications indirectly improve autoimmune conditions by lowering inflammation
Metabolic Dysfunction-Associated Steatotic Liver Disease Research A phase 2a MASLD substudy in Nature Medicine included 98 participants with metabolic dysfunction-associated steatotic liver disease and at least 10% liver fat [6]
Abdeen, Turgay Ayer, Aanan Biswas, Chase J